Bryan Johnson’s HBOT Results: What 60 Sessions Did to His Body
The world’s most measured man just published his hyperbaric oxygen therapy results — and the data is remarkable.
Bryan Johnson doesn’t do anything halfway. The tech entrepreneur and founder of Blueprint — the rigorous anti-aging protocol that has made him arguably the most measured human being on the planet — recently completed 60 sessions of hyperbaric oxygen therapy and published the results. For those unfamiliar, Johnson has spent years, and millions of dollars, systematically testing every therapy, supplement and intervention known to science in his quest to slow and reverse biological aging. His team of doctors and scientists measures everything. So when Bryan Johnson says something works, it comes with receipts.
That is what makes this result worth paying attention to. After achieving what he calls “elite-level biomarkers” over the past four years, Johnson and his team had struggled to find new therapies that could meaningfully move metrics that were already optimized. The well of easy wins had run dry. Hyperbaric oxygen was the rare intervention that still produced measurable change — in a body that is already one of the most finely-tuned on earth.
The protocol he ran
The specifics matter, because they are reproducible. Johnson used a hard-shell chamber at 2 ATA with 100% oxygen delivered via mask. That is not a wellness-spa soft chamber — it is the same class of pressure vessel, at the same pressure, used in the clinical trials that originally demonstrated HBOT’s effects on aging biomarkers. In other words, he didn’t invent a new protocol. He ran the one the research already pointed to, and measured himself against it with his usual rigor.
What the data showed
The results Johnson published draw on the body of peer-reviewed HBOT research his protocol was built around — and span several of the outcomes the longevity field cares about most:
- Telomere lengthening in healthy older adults, reported in a randomized clinical trial. Telomeres — the protective caps on our chromosomes — shorten as we age, so lengthening runs counter to the usual direction of travel.
- Improved VO₂ max, the gold-standard marker of cardiovascular fitness and one of the strongest predictors of longevity, in both elite athletes (age 40–50) and healthy adults (age 64+).
- Cognitive improvement and reduced amyloid burden in Alzheimer’s models and patients — amyloid being the protein associated with neurodegenerative decline.
- Senescent-cell reduction — fewer of the “zombie cells” that accumulate with age and drive chronic, low-grade inflammation throughout the body.
The mechanism behind all of it is elegant. Increased pressure enhances the body’s ability to dissolve and absorb oxygen, dramatically boosting oxygen concentration in every tissue — even those with compromised blood flow. That oxygen surplus is the raw material for healing, cellular repair, and the growth of new blood vessels (angiogenesis). Repeated across dozens of sessions, those acute effects appear to accumulate into the lasting biomarker changes Johnson measured.
Johnson ranks HBOT as “one of the highest value health therapies I’ve done.” Coming from someone who has systematically tested virtually everything available to modern science, that is about as strong an endorsement as exists.
Why this matters beyond one biohacker
It would be easy to file this under “things rich biohackers do.” That would be a mistake. The reason Johnson’s result is significant is precisely that it is not exotic. He didn’t use a one-off experimental device or a therapy available only to him. He used a hard-shell chamber running a 2 ATA, 100% oxygen protocol — the same type of chamber and the same protocol available to a clinic or a household today.
For most of HBOT’s history, the barrier was never the science — the clinical literature on oxygen, pressure and tissue repair goes back decades. The barriers were access and consistency: chambers lived in hospitals, sessions were expensive, and a protocol that depends on dozens of repeat visits rarely survived a real schedule. Both barriers have fallen. Clinical-grade chambers can now live in a home, which turns a 60-session protocol from a logistical ordeal into a daily habit.
The honest framing
None of this is a cure-all, and Johnson would be the first to say so — his entire method is about measurement, not hype. What his experiment demonstrates is narrower and more useful than a miracle claim: a reproducible protocol, run consistently, produced measurable movement in biomarkers that are notoriously hard to budge, in a person who had already optimized nearly everything else. For anyone serious about longevity, recovery, brain health, or simply performing at their best, that is a data point worth taking seriously.
- Johnson ran 60 sessions at 2 ATA with 100% oxygen via mask — and published the results.
- Reported effects spanned telomere lengthening, VO₂ max, cognition/amyloid, and senescent-cell reduction.
- He rates it among the highest-value therapies he has tested — from a man who has tested nearly all of them.
- The same protocol is available today in a hard-shell home or clinic chamber — access and consistency were the only barriers, and both have fallen.
Interested in bringing clinical-grade hyperbaric oxygen therapy into your home or practice? Explore the OxyPro range, dive into the science, or talk to our team.
